hsa_circ_0100181

ncRNA information

ncRNA name

hsa_circ_0100181

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

AMPK/mTOR signaling pathway

Cancer information

Cancer name

Acute Myeloid Leukemia

Cancer site

Leukemia

Treatment information

Treatment type

Chemotherapy

Drug

Adriamycin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

CircPAN3 may facilitate AML drug resistance through regulating autophagy and influencing expression of apoptosisrelated proteins, while AMPK/mTOR signaling plays a key role in the regulation of circPAN3 on autophagy.

Tissue resource

human acute myeloid leukemia cells THP-1

human acute myeloid leukemia cells K562

Experiment

qRT-PCR,Western blot


Institute

American Type Culture Collection

Country

USA

Continent

North American